blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1263459

EP1263459 - ATTENUATION OF FIBROBLAST PROLIFERATION [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  26.01.2007
Database last updated on 13.09.2024
Most recent event   Tooltip26.01.2007Refusal of applicationpublished on 28.02.2007  [2007/09]
Applicant(s)For all designated states
Ibex Technologies, Inc.
5 Great Valley Parkway, Suite 300
Malvern, PA 19355 / US
[2002/50]
Inventor(s)01 / DENHOLM, Elizabeth, M.
2 Victoria Avenue
Pointe Claire, Quebec H9S 4S3 / CA
02 / CAUCHON, Elizabeth
83 rue des Pins
Ile Perrot, Quebec J7V 8L6 / CA
03 / SILVER, Paul, J.
154 Barton Drive
Spring City, PA 19475-3418 / US
 [2002/50]
Representative(s)Miles, John Stephen
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2002/50]Miles, John Stephen
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date00980839.528.11.2000
[2002/50]
WO2000US32399
Priority number, dateUS19990168518P02.12.1999         Original published format: US 168518 P
[2002/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0139795
Date:07.06.2001
Language:EN
[2001/23]
Type: A2 Application without search report 
No.:EP1263459
Date:11.12.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2001 takes the place of the publication of the European patent application.
[2002/50]
Search report(s)International search report - published on:EP27.12.2001
ClassificationIPC:A61K38/46, A61K38/51, A61P17/00, A61P43/00
[2002/50]
CPC:
A61K38/51 (EP,US); A61P11/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/04 (EP);
A61P43/00 (EP); C12Y402/02019 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/50]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERMINDERUNG DER FIBROBLASTEN PROLIFERATION[2002/50]
English:ATTENUATION OF FIBROBLAST PROLIFERATION[2002/50]
French:ATTENUATION DE LA PROLIFERATION DE FIBROBLASTES[2002/50]
Entry into regional phase02.07.2002National basic fee paid 
02.07.2002Designation fee(s) paid 
02.07.2002Examination fee paid 
Examination procedure15.06.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.07.2002Examination requested  [2003/50]
03.07.2002Amendment by applicant (claims and/or description)
08.04.2003Despatch of a communication from the examining division (Time limit: M06)
16.10.2003Reply to a communication from the examining division
12.02.2004Despatch of a communication from the examining division (Time limit: M06)
03.08.2004Reply to a communication from the examining division
29.04.2005Despatch of communication that the application is refused, reason: substantive examination [2007/09]
09.01.2007Application refused, date of legal effect [2007/09]
Appeal following examination23.06.2005Appeal received No.  T1281/05
01.09.2005Statement of grounds filed
09.01.2007Result of appeal procedure: appeal of the applicant withdrawn
Divisional application(s)EP06077220.9  / EP1839671
Fees paidRenewal fee
26.11.2002Renewal fee patent year 03
12.11.2003Renewal fee patent year 04
22.11.2004Renewal fee patent year 05
29.11.2005Renewal fee patent year 06
27.11.2006Renewal fee patent year 07
Penalty fee
Penalty fee Rule 85a EPC 1973
02.10.2002AT   M02   Fee paid on   11.10.2002
02.10.2002BE   M02   Fee paid on   11.10.2002
02.10.2002CH   M02   Fee paid on   11.10.2002
02.10.2002CY   M02   Fee paid on   11.10.2002
02.10.2002DE   M02   Fee paid on   11.10.2002
02.10.2002DK   M02   Fee paid on   11.10.2002
02.10.2002ES   M02   Fee paid on   11.10.2002
02.10.2002FI   M02   Fee paid on   11.10.2002
02.10.2002FR   M02   Fee paid on   11.10.2002
02.10.2002GB   M02   Fee paid on   11.10.2002
02.10.2002GR   M02   Fee paid on   11.10.2002
02.10.2002IE   M02   Fee paid on   11.10.2002
02.10.2002IT   M02   Fee paid on   11.10.2002
02.10.2002LU   M02   Fee paid on   11.10.2002
02.10.2002MC   M02   Fee paid on   11.10.2002
02.10.2002NL   M02   Fee paid on   11.10.2002
02.10.2002PT   M02   Fee paid on   11.10.2002
02.10.2002SE   M02   Fee paid on   11.10.2002
02.10.2002TR   M02   Fee paid on   11.10.2002
Penalty fee Rule 85b EPC 1973
02.10.2002M02   Fee paid on   11.10.2002
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9513091  (INT TECH MANAGEMENT ASS [US], et al) [X] 1-4,9-15,17,18 * page 7, line 22 - page 8, line 4 * * page 8, line 31 - page 9, line 17 * * page 12, line 16 - page 14, line 8 * * page 17, line 26 - line 27 * * claims 1,16,17 *;
 [X]US5695752  (ROSEN STEVEN D [US], et al) [X] 1-7,9-11 * column 6, line 6 - column 7, line 5 * * column 13, line 17 - column 14, line 4 * * column 15, line 12 - column 16, line 62 *;
 [X]WO9846258  (BETH ISRAEL HOSPITAL [US]) [X] 1-5,8-19 * the whole document *;
 [X]WO9948478  (INSIGHT STRATEGY & MARKETING [IL], et al) [X] 1-5,8-19 * the whole document *;
 [X]  - DONATI L ET AL, "[Treatment of hypertrophic and keloid cicatrices with thiomucase]. Il trattamento delle cicatrici ipertrofiche e cheloidee mediante thiomucase.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, Database accession no. 76196588, URL: STN, XP002169931 [X] 1,6,8-11 * abstract *
    [ ] - MINERVA CHIRURGICA, (1975 MAR 31) 30 (6) 326-33.
 [A]  - DENHOLM ELIZABEITH M, "Inhibition of fibroblast proliferation by chondroitinase AC(CAC) and chondroitinase B(CB).", FASEB JOURNAL, Annual Meeting of the Professional Research Scientists on Experimental Biology 98, Part II;San Francisco, California, USA; April 18-22, 1998, (19980320), vol. 12, no. 5, ISSN 0892-6638, page A948, XP002169930 [A] 1-19 * the whole document *
 [T]  - DENHOLM ELIZABETH M ET AL, "Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate.", EUROPEAN JOURNAL OF PHARMACOLOGY, (2000), vol. 400, no. 2-3, ISSN 0014-2999, pages 145 - 153, XP001009717 [T] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0014-2999(00)00381-2
ExaminationWO0135977
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.